Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
about
Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cellsAntenatal screening for fetomaternal alloimmune thrombocytopenia: an evaluation using the criteria of the UK National Screening Committee.Platelet glycoprotein complex Ia/IIa antibodies cause neonatal alloimmune thrombocytopenia but do not inhibit megakaryopoiesis and platelet recovery after allogeneic cord blood stem cell transplantation.Kell expression on myeloid progenitor cells.Kell alloimmunization in pregnancy: associated with fetal thrombocytopenia?The outcome of pregnancy in Kell alloimmunisation.Haemolytic disease of the newbornSevere haemolytic disease of the newborn due to anti-Js(b).Maternal anti-M induced hemolytic disease of newborn followed by prolonged anemia in newborn twinsHaemolytic disease of the fetus and newborn.The clinical outcome of non-RhD antibody affected pregnancies in Northern Ireland.Associations of Rhesus and non-Rhesus maternal red blood cell alloimmunization with stillbirth and preterm birth.Recommendations for the prevention and treatment of haemolytic disease of the foetus and newborn.Bilateral cystic encephalomalacia following multiple intrauterine transfusions for anti-Kell isoimmunisation.Disorders of the fetomaternal unit: hematologic manifestations in the fetus and neonateIsolated anaemia as a manifestation of Rh isoimmunisationDistribution of Kell phenotype among pregnant women in Sokoto, North Western Nigeria.Anti-Ge3 causes late-onset hemolytic disease of the newborn: the fourth case in three Hispanic families.The value of DNA analysis for antigens of the Kell and Kx blood group systems.An easy and efficient strategy for KEL genotyping in a multiethnic population.Transfusion of murine red blood cells expressing the human KEL glycoprotein induces clinically significant alloantibodies.Clinically significant anti-KEL RBC alloantibodies are transferred by breast milk in a murine model.Alloantibodies to a paternally derived RBC KEL antigen lead to hemolytic disease of the fetus/newborn in a murine modelMiddle cerebral artery Doppler.Hydrops Fetalis due to Kell Alloimmunization: A Perinatal Approach to a Rare Case.Long-term neurodevelopmental and cardiovascular outcome after intrauterine transfusions for fetal anaemia: a review.Successful management of severe hemolytic disease of the fetus due to anti-Jsb using intrauterine transfusions with serial maternal blood donations: a case report and a review of the literature.Provision of KEL1-negative blood to obstetric patients: a 3-year single-institution retrospective review.Anti-K1 (Kell) Antibody Expressed in Maternal Breastmilk: A Case Report of a Neonate with Multiple Intrauterine Transfusions and Postnatal Exposure to Kell Antibody in Maternal Breastmilk.A rare, potentially life-threatening presentation of passenger lymphocyte syndrome.Antibody-mediated glycophorin C coligation on K562 cells induces phosphatidylserine exposure and cell death in an atypical apoptotic process.Solving the dilemma of prevention of red cell alloimmunization.Insights into the structure and function of membrane polypeptides carrying blood group antigens.The prevalence of anti-K in Canadian prenatal patients.Neonatal pure red cell aplasia due to anti-M.Derivated fetal haemoglobin as a marker for red cell age in the human fetus reflecting stimulated or impaired red blood cell production.Three novel alleles in the Kell blood group system resulting in the Knull phenotype and the first in a Native American.Late onset neonatal anaemia due to maternal anti-Ge: possible association with destruction of eythroid progenitors.Use of red cells preserved in extended storage media for exchange transfusion in anti-k haemolytic disease of the newborn.Onset of expression of the components of the Kell blood group complex.
P2860
Q28364279-1BDE2DA2-0F20-4694-934D-8281C1CE9B6FQ33335457-0BCB867C-413F-4EA3-BE4D-CCF42E6BEB72Q33340521-A2043D8B-28C0-4EB2-830D-165FDE5947CEQ33342352-BF95D240-1B19-4A75-8AF6-39BC2124446DQ33379397-E00CA4A1-70B9-4DCE-B0A8-BB29004B52B4Q33888117-DEE9C670-38AF-4D77-BF05-919C8D7437FDQ34002760-A623074D-A5DA-45AE-801E-93DEA9D1EE12Q34368575-4FA29D1E-BF86-4727-95E1-00759535C53DQ34464845-C82AF369-D9A4-4290-B75E-5A3D2F7456B2Q34472967-3DB9B3D4-EF57-4DBE-B68F-6A55C9035692Q34497828-473C97FF-3851-4C9F-B3A1-97297A52AEFEQ34649262-C485500B-D640-4250-9E15-19545A0612B1Q35049179-34F7E492-2105-4862-BF06-21777A9D200DQ35280959-FB340DDD-E3A9-44F4-92C1-3C39E0C7AC2AQ35599094-BF7F060E-054D-4325-9E57-3823125D4463Q35685915-5A0E6DB1-4226-4994-B1A3-FDA030DFAA00Q36251017-1EA9CDD2-F078-43CB-9BDD-2694736F7962Q36783594-F5F1C395-2AB4-42F6-B102-782512127043Q36861127-1B5DDEE3-504B-4395-873E-65C8BC76A9D3Q36901385-C85CB709-0F82-417E-8DBA-0EEE7E5EFD88Q37067373-9698CED7-9495-4A09-BBE1-5E48013FC1A0Q37079801-FE7FE025-37F8-428A-9481-38E08EDC8963Q37113092-94BBDB3C-A75C-4643-83CE-BB320B8EBFB6Q37259071-4E8D0C38-773C-4044-B27C-C76C5C097DBFQ37702853-B8E1B5D4-EF97-4F49-8804-AA8B1644AAEFQ38105309-5EC029A0-53C2-4E36-BF4C-B8EE399BB410Q38119499-51790B6F-84B0-4333-A871-B825043E7795Q38239446-38B8392E-B9F3-45A9-BD6E-7C6B5C1C86A4Q39207910-36BCA1B6-E126-4854-B070-9DD69D6DB5FCQ39215748-3AAAFAEC-61DD-4A5F-858B-4F652B5E7B73Q39218377-04F4BBD2-B200-4463-8613-AAABDC73E5B6Q39540151-6CC978CD-5AC6-4299-953E-810753087676Q40846483-2035D582-C8DD-483A-95A4-D1CBFAD07965Q40945341-8DE6F38D-5132-4038-97F7-EE25F01C53E3Q43141779-6C7F1D04-17C9-4B72-8857-49B84A1AE558Q43700623-03CAF709-2D05-47EC-9B4A-92124084CA2BQ43893889-BDE96FE6-2715-4CF3-997A-9818C90A384FQ46462392-AF141F6D-E2E8-458A-89BF-9545AF2498C1Q46462396-3BE9E9B7-D8EE-4CAD-8FF4-3A5E95EBFA49Q46526707-A2405B47-79A8-4632-9BCC-4CD04D6A903C
P2860
Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia.
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@ast
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@en
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@nl
type
label
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@ast
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@en
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@nl
prefLabel
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@ast
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@en
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@nl
P2093
P1476
Inhibition of erythroid progen ...... es in fetal alloimmune anemia.
@en
P2093
P304
P356
10.1056/NEJM199803193381204
P407
P577
1998-03-01T00:00:00Z